[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@ThePharmaLetter](/creator/twitter/ThePharmaLetter)
"Grifols Biotest to launch Yimmugo in USA"  
[X Link](https://x.com/ThePharmaLetter/status/1976666619180122204) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-10T15:10Z 25.3K followers, XXX engagements


"@sanofi's high-dose influenza vaccine demonstrates superior protection"  
[X Link](https://x.com/ThePharmaLetter/status/1980542022646686064) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-21T07:49Z 25.3K followers, XX engagements


"Acquisition strengthens @AspirePharmas strategic portfolio"  
[X Link](https://x.com/ThePharmaLetter/status/1981063150892909036) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-22T18:20Z 25.3K followers, XXX engagements


"Ipsen lifts guidance as rare disease sales surge in third quarter"  
[X Link](https://x.com/ThePharmaLetter/status/1981063919805551066) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-22T18:23Z 25.3K followers, XXX engagements


"Ipsen to acquire French biotech ImCheck"  
[X Link](https://x.com/ThePharmaLetter/status/1981064355367309504) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-22T18:25Z 25.3K followers, XXX engagements


"Bristol Myers to launch Cobenfy in UK at a list price equal to the USA"  
[X Link](https://x.com/ThePharmaLetter/status/1970854508998824421) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-09-24T14:15Z 25.3K followers, XXX engagements


"@Celltrioninc presents positive RWE on switching from IV to SC infliximab"  
[X Link](https://x.com/ThePharmaLetter/status/1975581046767759483) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-07T15:16Z 25.3K followers, XX engagements


"@novonordisk axes cell therapy research in sweeping overhaul"  
[X Link](https://x.com/ThePharmaLetter/status/1978018364774547604) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-14T08:41Z 25.3K followers, XX engagements


"India's @NATCOPharmaLtd takes $226m strategic stake in Adcock Ingram"  
[X Link](https://x.com/ThePharmaLetter/status/1978019449765527659) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-14T08:46Z 25.3K followers, XXX engagements


"@Regeneron plans FDA filing based on latest DB-OTO data"  
[X Link](https://x.com/ThePharmaLetter/status/1978019625435631889) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-14T08:46Z 25.3K followers, XX engagements


"@AstellasUS' zolbetuximab misses Phase II goal"  
[X Link](https://x.com/ThePharmaLetter/status/1978780568155234502) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-16T11:10Z 25.3K followers, XX engagements


"@OmerosCorp rockets on news of deal with @novonordisk"  
[X Link](https://x.com/ThePharmaLetter/status/1978780782081519832) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-16T11:11Z 25.3K followers, XX engagements


"@GileadSciences highlights HIV pipeline at European AIDS Conference"  
[X Link](https://x.com/ThePharmaLetter/status/1978781627397419414) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-16T11:14Z 25.3K followers, XX engagements


"ESMO 2025: PSMAddition data show @Novartis Pluvicto delays prostate cancer progression"  
[X Link](https://x.com/ThePharmaLetter/status/1980302261025927676) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-20T15:57Z 25.3K followers, XXX engagements


"@novonordisk's oral GLP-1 approved to cut MACE risk in type X diabetes patients"  
[X Link](https://x.com/ThePharmaLetter/status/1980307665709658460) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-20T16:18Z 25.3K followers, XX engagements


"FDA accepts @sanofi's Tzield for expedited review"  
[X Link](https://x.com/ThePharmaLetter/status/1980308285191499865) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-20T16:21Z 25.3K followers, XXX engagements


"Elevara Medicines closes $XX million Series A financing"  
[X Link](https://x.com/ThePharmaLetter/status/1981063721939325366) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-22T18:22Z 25.3K followers, XXX engagements


"@Merck commits over $70B to US R&D center"  
[X Link](https://x.com/ThePharmaLetter/status/1981064149842219230) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-22T18:24Z 25.3K followers, XX engagements


"@sanofi's efdoralprin alfa meets Phase II endpoints"  
[X Link](https://x.com/ThePharmaLetter/status/1981064261439836277) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-22T18:25Z 25.3K followers, XX engagements


"Breakthrough designation for @Genmabs Rina-S in USA"  
[X Link](https://x.com/ThePharmaLetter/status/1960974454424519164) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-08-28T07:55Z 25.3K followers, XXX engagements


"Change goes on at @novonordisk with new board to be elected"  
[X Link](https://x.com/ThePharmaLetter/status/1981064695218934056) [@ThePharmaLetter](/creator/x/ThePharmaLetter) 2025-10-22T18:26Z 25.3K followers, XXX engagements